Cargando…

Divergent and dominant anti-inflammatory effects of patient-derived anticitrullinated protein antibodies (ACPA) in arthritis development

Detalles Bibliográficos
Autores principales: Raposo, Bruno, Afonso, Marcelo, Israelsson, Lena, Wähämaa, Heidi, Stålesen, Ragnhild, Wermeling, Fredrik, Hensvold, Aase Haj, Grönwall, Caroline, Rethi, Bence, Klareskog, Lars, Malmström, Vivianne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176372/
https://www.ncbi.nlm.nih.gov/pubmed/36604150
http://dx.doi.org/10.1136/ard-2022-223417
_version_ 1785040420103782400
author Raposo, Bruno
Afonso, Marcelo
Israelsson, Lena
Wähämaa, Heidi
Stålesen, Ragnhild
Wermeling, Fredrik
Hensvold, Aase Haj
Grönwall, Caroline
Rethi, Bence
Klareskog, Lars
Malmström, Vivianne
author_facet Raposo, Bruno
Afonso, Marcelo
Israelsson, Lena
Wähämaa, Heidi
Stålesen, Ragnhild
Wermeling, Fredrik
Hensvold, Aase Haj
Grönwall, Caroline
Rethi, Bence
Klareskog, Lars
Malmström, Vivianne
author_sort Raposo, Bruno
collection PubMed
description
format Online
Article
Text
id pubmed-10176372
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-101763722023-05-13 Divergent and dominant anti-inflammatory effects of patient-derived anticitrullinated protein antibodies (ACPA) in arthritis development Raposo, Bruno Afonso, Marcelo Israelsson, Lena Wähämaa, Heidi Stålesen, Ragnhild Wermeling, Fredrik Hensvold, Aase Haj Grönwall, Caroline Rethi, Bence Klareskog, Lars Malmström, Vivianne Ann Rheum Dis Letter BMJ Publishing Group 2023-05 2023-01-05 /pmc/articles/PMC10176372/ /pubmed/36604150 http://dx.doi.org/10.1136/ard-2022-223417 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.
spellingShingle Letter
Raposo, Bruno
Afonso, Marcelo
Israelsson, Lena
Wähämaa, Heidi
Stålesen, Ragnhild
Wermeling, Fredrik
Hensvold, Aase Haj
Grönwall, Caroline
Rethi, Bence
Klareskog, Lars
Malmström, Vivianne
Divergent and dominant anti-inflammatory effects of patient-derived anticitrullinated protein antibodies (ACPA) in arthritis development
title Divergent and dominant anti-inflammatory effects of patient-derived anticitrullinated protein antibodies (ACPA) in arthritis development
title_full Divergent and dominant anti-inflammatory effects of patient-derived anticitrullinated protein antibodies (ACPA) in arthritis development
title_fullStr Divergent and dominant anti-inflammatory effects of patient-derived anticitrullinated protein antibodies (ACPA) in arthritis development
title_full_unstemmed Divergent and dominant anti-inflammatory effects of patient-derived anticitrullinated protein antibodies (ACPA) in arthritis development
title_short Divergent and dominant anti-inflammatory effects of patient-derived anticitrullinated protein antibodies (ACPA) in arthritis development
title_sort divergent and dominant anti-inflammatory effects of patient-derived anticitrullinated protein antibodies (acpa) in arthritis development
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10176372/
https://www.ncbi.nlm.nih.gov/pubmed/36604150
http://dx.doi.org/10.1136/ard-2022-223417
work_keys_str_mv AT raposobruno divergentanddominantantiinflammatoryeffectsofpatientderivedanticitrullinatedproteinantibodiesacpainarthritisdevelopment
AT afonsomarcelo divergentanddominantantiinflammatoryeffectsofpatientderivedanticitrullinatedproteinantibodiesacpainarthritisdevelopment
AT israelssonlena divergentanddominantantiinflammatoryeffectsofpatientderivedanticitrullinatedproteinantibodiesacpainarthritisdevelopment
AT wahamaaheidi divergentanddominantantiinflammatoryeffectsofpatientderivedanticitrullinatedproteinantibodiesacpainarthritisdevelopment
AT stalesenragnhild divergentanddominantantiinflammatoryeffectsofpatientderivedanticitrullinatedproteinantibodiesacpainarthritisdevelopment
AT wermelingfredrik divergentanddominantantiinflammatoryeffectsofpatientderivedanticitrullinatedproteinantibodiesacpainarthritisdevelopment
AT hensvoldaasehaj divergentanddominantantiinflammatoryeffectsofpatientderivedanticitrullinatedproteinantibodiesacpainarthritisdevelopment
AT gronwallcaroline divergentanddominantantiinflammatoryeffectsofpatientderivedanticitrullinatedproteinantibodiesacpainarthritisdevelopment
AT rethibence divergentanddominantantiinflammatoryeffectsofpatientderivedanticitrullinatedproteinantibodiesacpainarthritisdevelopment
AT klareskoglars divergentanddominantantiinflammatoryeffectsofpatientderivedanticitrullinatedproteinantibodiesacpainarthritisdevelopment
AT malmstromvivianne divergentanddominantantiinflammatoryeffectsofpatientderivedanticitrullinatedproteinantibodiesacpainarthritisdevelopment